CUMYL-CB-MEGACLONE

CUMYL-CB-MEGACLONE
Legal status
Legal status	UK: Under Psychoactive Substances Act;
Identifiers
	IUPAC name 2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-(cyclobutylmethyl)-1H-pyrido[4,3-b]indol-1-one;
CAS Number	2806439-13-2;
PubChem CID	155884737;
UNII	U43QX7LH63;
Chemical and physical data
Formula	C25H26N2O
Molar mass	370.496 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)(c1ccccc1)N5C=Cc4n(CC2CCC2)c3ccccc3c4C5=O;
	InChI InChI=1S/C25H26N2O/c1-25(2,19-11-4-3-5-12-19)27-16-15-22-23(24(27)28)20-13-6-7-14-21(20)26(22)17-18-9-8-10-18/h3-7,11-16,18H,8-10,17H2,1-2H; Key:XABXFXHKUHKHFO-UHFFFAOYSA-N;

CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in April 2020.^[1]

References

^ Analytical data for Cumyl-Cb-MeGaClone. Hungarian Institute for Forensic Science, 9 April 2020

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

[1] Analytical data for Cumyl-Cb-MeGaClone. Hungarian Institute for Forensic Science, 9 April 2020

[1]

See also

References